학술논문
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Document Type
Artikel
Author
Sussmuth, SD; Haider, S; Landwehrmeyer, GB; Farmer, R; Frost, C; Tripepi, G; Andersen, CA; Di Bacco, M; Lamanna, C; Diodato, E; Massai, L; Diamanti, D; Mori, E; Magnoni, L; Dreyhaupt, J; Schiefele, K; Craufurd, D; Saft, C; Rudzinska, M; Ryglewicz, D; Orth, M; Brzozy, S; Baran, A; Pollio, G; Andre, R; Tabrizi, SJ; Darpo, B; Westerberg, G
Source
British journal of clinical pharmacology. 79(3):465-476
Subject
Language
English
English
English
ISSN
1365-2125